Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
出版年份 2021 全文链接
标题
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
作者
关键词
-
出版物
Viruses-Basel
Volume 13, Issue 7, Pages 1271
出版商
MDPI AG
发表日期
2021-06-30
DOI
10.3390/v13071271
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
- (2021) Julia Maria Ressler et al. Journal for ImmunoTherapy of Cancer
- Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
- (2021) Georgia M Beasley et al. Journal for ImmunoTherapy of Cancer
- Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
- (2021) Elizaveta Sergeevna Podshivalova et al. Molecular Therapy-Oncolytics
- Recommendations for the nomenclature of enteroviruses and rhinoviruses
- (2020) P. Simmonds et al. ARCHIVES OF VIROLOGY
- Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy
- (2020) Siri Tähtinen et al. CANCER RESEARCH
- Structure of the Vesicular Stomatitis Virus L Protein in Complex with Its Phosphoprotein Cofactor
- (2020) Simon Jenni et al. Cell Reports
- Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
- (2020) Asmita Pal et al. Frontiers in Microbiology
- Repurposing infectious disease vaccines for intratumoral immunotherapy
- (2020) Ignacio Melero et al. Journal for ImmunoTherapy of Cancer
- Ofranergene obadenovec (VB-111) in platinum-resistant ovarian cancer; favorable response rates in a phase I/II study are associated with an immunotherapeutic effect
- (2020) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.
- (2020) Mark R. Middleton et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship of infusion duration to safety, efficacy, and pharmacodynamics (PD): Second part of a phase I-II study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors.
- (2020) Jaime R. Merchan et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors
- (2020) Carolini Kaid et al. MOLECULAR THERAPY
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
- (2020) Lorenzo Galluzzi et al. Journal for ImmunoTherapy of Cancer
- Assessing the oncolytic potential of rotavirus on mouse myeloma cell line Sp2/0-Ag14
- (2020) Rafael A. Guerrero et al. Biomedica
- CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas
- (2020) Aamir Ahmad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)
- (2020) Séan M. O’Cathail et al. Radiation Oncology
- Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma
- (2020) Sam Keeping et al. Future Oncology
- Clinical Application of Oncolytic Viruses: A Systematic Review
- (2020) Mary Cook et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
- (2020) Edurne Rujas et al. Nature Communications
- Clinical landscape of oncolytic virus research in 2020
- (2020) Nicholas Macedo et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
- (2020) June Kyu Hwang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
- (2020) Bharat Burman et al. Cancers
- A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
- (2019) Jean-Pascal Machiels et al. Journal for ImmunoTherapy of Cancer
- Two roads for oncolytic immunotherapy development
- (2019) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
- (2019) James L. Gulley et al. JOURNAL OF CLINICAL ONCOLOGY
- Poxvirus Oncolytic virotherapy
- (2019) Lino E. Torres-Domínguez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
- (2019) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019)
- (2019) Peter J. Walker et al. ARCHIVES OF VIROLOGY
- Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21
- (2019) Nicola E Annels et al. CLINICAL CANCER RESEARCH
- Achieving systemic delivery of oncolytic viruses
- (2019) Claudia Hill et al. Expert Opinion on Drug Delivery
- Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
- (2019) Julia Niemann et al. Nature Communications
- Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
- (2019) M. Moehler et al. OncoImmunology
- First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells
- (2019) Boris R. Minev et al. Journal of Translational Medicine
- Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
- (2019) Anahita Fathi et al. Human Vaccines & Immunotherapeutics
- Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
- (2019) Suzanne Thomas et al. Journal for ImmunoTherapy of Cancer
- 1213PSingle intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumour immunity
- (2019) A Samson et al. ANNALS OF ONCOLOGY
- Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
- (2019) Devalingam Mahalingam et al. CLINICAL CANCER RESEARCH
- Repurposing the yellow fever vaccine for intratumoral immunotherapy
- (2019) Maria Angela Aznar et al. EMBO Molecular Medicine
- ICTV Virus Taxonomy Profile: Paramyxoviridae
- (2019) Bert Rima et al. JOURNAL OF GENERAL VIROLOGY
- Experimental evolution generates novel oncolytic vesicular stomatitis viruses with improved replication in virus-resistant pancreatic cancer cells
- (2019) Sara L. Seegers et al. JOURNAL OF VIROLOGY
- Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir
- (2019) Guna Proboka et al. MEDICINE
- Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
- (2019) Shuang Qin et al. Molecular Cancer
- Intratumoral Immunotherapy—Update 2019
- (2019) Omid Hamid et al. ONCOLOGIST
- A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study
- (2019) Erin L. Schenk et al. Journal of Thoracic Oncology
- Rhabdoviruses as vaccine platforms for infectious disease and cancer
- (2018) Franz Zemp et al. Biotechnology & Genetic Engineering Reviews
- Phase I study of oncolytic vaccinia virus GL-ONC1 in patients with peritoneal carcinomatosis
- (2018) Ulrich M. Lauer et al. CLINICAL CANCER RESEARCH
- A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial
- (2018) Derek J. Jonker et al. Clinical Colorectal Cancer
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes
- (2018) Amir-Babak Sioofy-Khojine et al. DIABETOLOGIA
- Unleashing the therapeutic potential of oncolytic viruses
- (2018) Praveen K. Bommareddy et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II trial of pexa-vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, in patients with metastatic, refractory renal cell carcinoma (RCC).
- (2018) Seong-Geun Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- The Immune System in Oncolytic Immunovirotherapy: Gospel, Schism and Heresy
- (2018) Richard G. Vile MOLECULAR THERAPY
- Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
- (2018) Jacob M. Ricca et al. MOLECULAR THERAPY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
- (2018) Suman Bishnoi et al. Viruses-Basel
- Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference
- (2018) Arthur Dyer et al. CANCER GENE THERAPY
- Abstract CT072: First in human (FIH) dose escalation studies of intravenous administration of VSV-IFNβ-NIS (Voyager-V1™) in Stage IV or recurrent endometrial cancer
- (2018) Jamie Bakkum-Gamez et al. CANCER RESEARCH
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- (2018) Pēteris Alberts et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
- (2018) Jonathan G. Pol et al. OncoImmunology
- The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
- (2018) Ibrahim Eissa et al. Cancers
- Oncolytic herpes simplex virus and immunotherapy
- (2018) Wenqing Ma et al. BMC IMMUNOLOGY
- Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus
- (2018) Riikka Havunen et al. Molecular Therapy-Oncolytics
- Strategy to detect pre-existing immunity to AAV gene therapy
- (2017) L Falese et al. GENE THERAPY
- Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
- (2017) Sébastien A. Felt et al. JOURNAL OF GENERAL VIROLOGY
- Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
- (2017) A Dispenzieri et al. LEUKEMIA
- Biomarkers of prostate cancer sensitivity to the Sendai virus
- (2017) A. A. Belova et al. MOLECULAR BIOLOGY
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients
- (2017) Sonia Tejada et al. NEUROSURGERY
- Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial
- (2017) Jie Xiao et al. Oncology Letters
- Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
- (2017) Lauro Velazquez-Salinas et al. Human Gene Therapy Clinical Development
- Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
- (2017) Dana Haddad Frontiers in Oncology
- Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
- (2016) Praveen K. Bommareddy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
- (2016) Xiaozhu Li et al. CLINICAL CANCER RESEARCH
- Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
- (2016) Adel Samson et al. GUT
- Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma
- (2016) Robert H. I. Andtbacka et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
- (2016) Stephanie Downs-Canner et al. MOLECULAR THERAPY
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Differential expression of TYRP1 in adult human retinal pigment epithelium and uveal melanoma cells
- (2016) CHUN QIU et al. Oncology Letters
- Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models
- (2016) Eda K. Holl et al. Oncotarget
- Intratumoral immunotherapy for melanoma
- (2015) Manisha Singh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Arming oncolytic viruses to leverage antitumor immunity
- (2015) Tanja D de Gruijl et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccinia virus, a promising new therapeutic agent for pancreatic cancer
- (2015) Chadwan Al Yaghchi et al. Immunotherapy
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
- (2015) Simona Doniņa et al. MELANOMA RESEARCH
- First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity
- (2015) Herbert J Zeh et al. MOLECULAR THERAPY
- Efficacy of recombinant adenoviral human p53 gene in the treatment of lung cancer-mediated pleural effusion
- (2015) KUN-LIN LI et al. Oncology Letters
- Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy
- (2015) Otto Hemminki et al. Oncotarget
- Oncolytic viruses: perspectives on clinical development
- (2015) James Burke et al. Current Opinion in Virology
- Oncolysis by paramyxoviruses: preclinical and clinical studies
- (2015) Olga V Matveeva et al. Molecular Therapy-Oncolytics
- Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial
- (2014) Yi Li et al. BMC Medicine
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- Utilizing adenovirus vectors for gene delivery in cancer
- (2014) Dayananda Kasala et al. Expert Opinion on Drug Delivery
- Sensitivity of the Polymerase of Vesicular Stomatitis Virus to 2′ Substitutions in the Template and Nucleotide Triphosphate during Initiation and Elongation
- (2014) Benjamin Morin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vesiculovirus Neutralization by Natural IgM and Complement
- (2014) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5
- (2014) Jun Dong et al. MEDICAL ONCOLOGY
- The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site
- (2014) Vanesa Alonso-Camino et al. MOLECULAR THERAPY
- TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial
- (2014) Brigitte Dreno et al. PLoS One
- Pre-existing immunity against Ad vectors
- (2014) Hugues Fausther-Bovendo et al. Human Vaccines & Immunotherapeutics
- Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
- (2014) Xiang Wang et al. Emerging Microbes & Infections
- Viral therapy for pancreatic cancer: Tackle the bad guys with poison
- (2013) Can Xu et al. CANCER LETTERS
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function
- (2013) Volker Schirrmacher et al. Expert Review of Vaccines
- Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans
- (2013) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
- (2013) Manfred Westphal et al. LANCET ONCOLOGY
- Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor
- (2013) Alejandro Francisco-Cruz et al. MEDICAL ONCOLOGY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
- (2012) E. M. Karapanagiotou et al. CLINICAL CANCER RESEARCH
- Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets
- (2012) Gunnel Halldén et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
- (2012) Dmitriy Zamarin et al. Future Microbiology
- Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy
- (2012) V Roulstone et al. GENE THERAPY
- Oncolytic enteroviruses
- (2012) P. M. Chumakov et al. MOLECULAR BIOLOGY
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
- (2012) Jose Pulido et al. NATURE BIOTECHNOLOGY
- ViralZone: recent updates to the virus knowledge resource
- (2012) Patrick Masson et al. NUCLEIC ACIDS RESEARCH
- Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus
- (2012) A. A. Rahmeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical research on recombinant human Ad-p53 injection combined with cisplatin in treatment of malignant pleural effusion induced by lung cancer
- (2012) Wei-Zhu Zhao et al. Chinese Journal of Cancer
- Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells
- (2011) Michael Fasullo et al. CELL CYCLE
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Targeting Tumor Vasculature With an Oncolytic Virus
- (2011) Caroline J Breitbach et al. MOLECULAR THERAPY
- Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells
- (2011) Xinping Fu et al. MOLECULAR THERAPY
- Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
- (2011) Gough G Au et al. Virology Journal
- Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer
- (2010) Phonphimon Wongthida et al. CANCER RESEARCH
- Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic
- (2010) C. M. Thirukkumaran et al. CANCER RESEARCH
- Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
- (2010) E. Galanis et al. CANCER RESEARCH
- A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
- (2010) M. P. Lolkema et al. CLINICAL CANCER RESEARCH
- Therapeutic Potential of Oncolytic Measles Virus: Promises and Challenges
- (2010) E Galanis CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
- (2010) K.J. Harrington et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncolytic parvoviruses as cancer therapeutics
- (2010) Jean Rommelaere et al. CYTOKINE & GROWTH FACTOR REVIEWS
- MAGE A3 antigen-specific cancer immunotherapeutic
- (2010) Nir Peled et al. Immunotherapy
- New perspectives in cancer virotherapy: bringing the immune system into play
- (2010) Nicolas Boisgerault et al. Immunotherapy
- Enhancement of NK cell antitumor responses using an oncolytic parvovirus
- (2010) Rauf Bhat et al. INTERNATIONAL JOURNAL OF CANCER
- Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy
- (2010) Paul T Sobol et al. MOLECULAR THERAPY
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Herpesvirus systematics
- (2010) Andrew J. Davison VETERINARY MICROBIOLOGY
- Expression of IFN- Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
- (2009) C. L. Willmon et al. CANCER RESEARCH
- Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma
- (2009) Zhi-xiang Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Activated Ras/MEK Inhibits the Antiviral Response of Alpha Interferon by Reducing STAT2 Levels
- (2009) S. L. Christian et al. JOURNAL OF VIROLOGY
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
- (2009) G. Wollmann et al. JOURNAL OF VIROLOGY
- Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter
- (2009) Pavlos Msaouel et al. MOLECULAR THERAPY
- Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
- (2009) Jennifer Altomonte et al. MOLECULAR THERAPY
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Measles Virus as An Oncolytic Vector Platform
- (2008) Boris Blechacz et al. CURRENT GENE THERAPY
- Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide
- (2008) Mark A Currier et al. MOLECULAR THERAPY
- The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More